Journal of Cancer Therapy

Volume 2, Issue 5 (December 2011)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

CuradermBEC5 for Skin Cancers, Is It? An Overview

HTML  XML Download Download as PDF (Size: 3513KB)  PP. 728-745  
DOI: 10.4236/jct.2011.25099    18,076 Downloads   30,923 Views  Citations
Author(s)

Affiliation(s)

.

ABSTRACT

Skin cancer incidence is increasing at alarming rates and is considered by some as an epidemic. Its incidence is higher than all other cancers combined. The developments of new treatments have not parallelled the increased incidences of this disease. A variety of treatments are available with differing outcomes. More recently a novel topical treatment, consisting of the antineoplastic compounds solasodine rhamnosyl glycosides, solamargine and solasonine, which are derived from plant material, has been described that claims to have many advantages over the currently used skin cancer therapies. This review investigates such claims.

Share and Cite:

T. Chase, "CuradermBEC5 for Skin Cancers, Is It? An Overview," Journal of Cancer Therapy, Vol. 2 No. 5, 2011, pp. 728-745. doi: 10.4236/jct.2011.25099.

Cited by

[1] The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma
Clin Med Rev Case Rep, 2022
[2] Squamous Cell Carcinoma (SCC) and Chronic Radiation Dermatitis Associated with Childhood Ionizing Radiation Exposure: Case Report with Review of the …
Journal of Skin and Stem …, 2021
[3] Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma
2020
[4] Evaluation of Dermal Irritation and Skin Sensitization by Curaderm
2020
[5] First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report
2020
[6] Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
2020
[7] Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
2017
[8] Опыт применения препарата Курадерм в лечении базально-клеточного рака кожи головы и шеи
2016
[9] The use of Kuraderm drug in the treatment of basal cell carcinoma of the head and neck
Head and Neck Tumors …, 2016
[10] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
2015
[11] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
2015
[12] Topical Cream Curadermbec5 Treats a Recalcitrant Basal Cell Carcinoma
2015
[13] A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: Relevance to BEC and solamargine, a topical clinical …
2015
[14] A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
Journal of Cancer Treatment and Research, 2015
[15] Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy, 2015
[16] Process to obtain an extract from solanum genus plants
2015
[17] Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
2013
[18] Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
International Journal of Clinical Medicine, 2013
[19] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5
Journal of Cancer Therapy, 2013
[20] Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm BEC5
2013
[21] Topical Curaderm BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
2013
[22] Intralesion and curaderm BEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or devil's apple result in rapid …
2012
[23] Intralesion and CuradermBEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil's Apple Result in …
2012
[24] Intralesion and CuradermBEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared
International Journal of Clinical Medicine, 2012
[25] Intralesion and curadermBEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or devil's apple result in rapid …
2012

Journals Menu
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.